SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001193125-15-322694
Filing Date
2015-09-18
Accepted
2015-09-17 21:57:43
Documents
13

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO FORM S-1 d948537ds1a.htm S-1/A 43305
2 EX-10.17 d948537dex1017.htm EX-10.17 1023179
3 EX-10.18 d948537dex1018.htm EX-10.18 400684
4 EX-10.19 d948537dex1019.htm EX-10.19 439984
5 EX-10.21 d948537dex1021.htm EX-10.21 256396
6 GRAPHIC g948762ex10_17pg55.jpg GRAPHIC 16803
7 GRAPHIC g948762ex10_18pg076.jpg GRAPHIC 27062
8 GRAPHIC g948762stamp074a.jpg GRAPHIC 3173
9 GRAPHIC g948762stamp074b.jpg GRAPHIC 2379
10 GRAPHIC g948762stamp087a.jpg GRAPHIC 3094
11 GRAPHIC g948762stamp087b.jpg GRAPHIC 2610
12 GRAPHIC g948762stamp093a.jpg GRAPHIC 3466
13 GRAPHIC g948762stamp093b.jpg GRAPHIC 4000
  Complete submission text file 0001193125-15-322694.txt   2251918
Mailing Address 650 GATEWAY BLVD. SUITE 125 SOUTH SAN FRANCISCO CA 94080
Business Address 650 GATEWAY BLVD. SUITE 125 SOUTH SAN FRANCISCO CA 94080 650.515.3185
CytomX Therapeutics, Inc. (Filer) CIK: 0001501989 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-206658 | Film No.: 151113894
SIC: 2834 Pharmaceutical Preparations